159 related articles for article (PubMed ID: 24164826)
1. Post-transplant lymphoproliferative disorder: no relationship to recombinant human growth hormone use in Australian and New Zealand pediatric kidney transplant recipients.
Longmore DK; Conwell LS; Burke JR; McDonald SP; McTaggart SJ
Pediatr Transplant; 2013 Dec; 17(8):731-6. PubMed ID: 24164826
[TBL] [Abstract][Full Text] [Related]
2. Post-transplantation lymphoproliferative disorder in pediatric kidney-transplant recipients - a national study.
Cleper R; Ben Shalom E; Landau D; Weissman I; Krause I; Konen O; Rahamimov R; Mor E; Bar-Nathan N; Frishberg Y; Davidovits M
Pediatr Transplant; 2012 Sep; 16(6):619-26. PubMed ID: 22708682
[TBL] [Abstract][Full Text] [Related]
3. Recombinant growth hormone use pretransplant and risk for post-transplant lymphoproliferative disease--a report of the NAPRTCS.
Dharnidharka VR; Talley LI; Martz KL; Stablein DM; Fine RN
Pediatr Transplant; 2008 Sep; 12(6):689-95. PubMed ID: 18179637
[TBL] [Abstract][Full Text] [Related]
4. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
Manlhiot C; Pollock-Barziv SM; Holmes C; Weitzman S; Allen U; Clarizia NA; Ngan BY; McCrindle BW; Dipchand AI
J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
[TBL] [Abstract][Full Text] [Related]
5. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
[TBL] [Abstract][Full Text] [Related]
6. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Nephrol Dial Transplant; 2012 Jul; 27(7):2971-9. PubMed ID: 22273720
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
8. Risk for post-transplant lymphoproliferative disorder after polyclonal antibody induction in kidney transplantation.
Dharnidharka VR; Stevens G
Pediatr Transplant; 2005 Oct; 9(5):622-6. PubMed ID: 16176420
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
Francis A; Johnson DW; Teixeira-Pinto A; Craig JC; Wong G
Nephrol Dial Transplant; 2018 May; 33(5):881-889. PubMed ID: 29342279
[TBL] [Abstract][Full Text] [Related]
10. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
[TBL] [Abstract][Full Text] [Related]
11. The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients.
Fine RN; Sullivan EK; Kuntze J; Blethen S; Kohaut E
J Pediatr; 2000 Mar; 136(3):376-82. PubMed ID: 10700696
[TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
14. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.
Caillard S; Porcher R; Provot F; Dantal J; Choquet S; Durrbach A; Morelon E; Moal V; Janbon B; Alamartine E; Pouteil Noble C; Morel D; Kamar N; Buchler M; Mamzer MF; Peraldi MN; Hiesse C; Renoult E; Toupance O; Rerolle JP; Delmas S; Lang P; Lebranchu Y; Heng AE; Rebibou JM; Mousson C; Glotz D; Rivalan J; Thierry A; Etienne I; Moal MC; Albano L; Subra JF; Ouali N; Westeel PF; Delahousse M; Genin R; Hurault de Ligny B; Moulin B
J Clin Oncol; 2013 Apr; 31(10):1302-9. PubMed ID: 23423742
[TBL] [Abstract][Full Text] [Related]
15. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
[TBL] [Abstract][Full Text] [Related]
16. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
Kim JM; Lee SK; Kim SJ; Joh JW; Kwon CH; Choe YH; Shin M; Kim EY; Moon JI; Jung GO; Choi GS
Transplant Proc; 2010 Apr; 42(3):895-9. PubMed ID: 20430199
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for post-transplant lymphoproliferative disease in patients with cystic fibrosis.
Saueressig MG; Boussaud V; Amrein C; Guillemain R; Souilamas J; Souilamas R
Clin Transplant; 2011; 25(4):E430-6. PubMed ID: 21518001
[TBL] [Abstract][Full Text] [Related]
19. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
20. Growth, chronic kidney disease and pediatric kidney transplantation: is it useful to use recombinant growth hormone in Colombian children with renal transplant?
Castañeda DA; López LF; Ovalle DF; Buitrago J; Rodríguez D; Lozano E
Transplant Proc; 2011 Nov; 43(9):3344-9. PubMed ID: 22099793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]